Brain Imaging in Cases with Positive Serology for Dengue with Neurologic Symptoms: A Clinicoradiologic Correlation

References

1. 1.↵
   Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: World Health Organization; 2009 (WHO Guidelines Approved by the Guidelines Review Committee). http://www.ncbi.nlm.nih.gov/books/NBK143157/. Accessed April 18, 2017.
2. 2.↵
   WHO. Epidemiology. Dengue control. http://www.who.int/denguecontrol/epidemiology/en/. Accessed November 13, 2017.
3. 3.↵
   2. Solomon T,
   3. Dung NM,
   4. Vaughn DW, et al

   . Neurological manifestations of dengue infection. Lancet 2000;355:1053–59 doi:10.1016/S0140-6736(00)02036-5

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Pancharoen C,
   3. Thisyakorn U

   . Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health 2001;32:341–45 pmid:11556587

   PubMed
5. 5.↵
   2. Verma R,
   3. Sharma P,
   4. Garg RK, et al

   . Neurological complications of dengue fever: experience from a tertiary center of north India. Ann Indian Acad Neurol 2011;14:272–78 doi:10.4103/0972-2327.91946 pmid:22346016

   CrossRefPubMed
6. 6.↵
   2. Bhoi SK,
   3. Naik S,
   4. Kumar S, et al

   . Cranial imaging findings in dengue virus infection. J Neurol Sci 2014;342:36–41 doi:10.1016/j.jns.2014.04.018 pmid:24814949

   CrossRefPubMed
7. 7.↵
   2. Kamble R,
   3. Peruvamba JN,
   4. Kovoor J, et al

   . Bilateral thalamic involvement in dengue infection. Neurol India 2007;55:418–19 doi:10.4103/0028-3886.37103 pmid:18040126

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Wasay M,
   3. Channa R,
   4. Jumani M, et al

   . Encephalitis and myelitis associated with dengue viral infection clinical and neuroimaging features. Clin Neurol Neurosurg 2008;110:635–40 doi:10.1016/j.clineuro.2008.03.011 pmid:18467022

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Hegde V,
   3. Aziz Z,
   4. Kumar S, et al

   . Dengue encephalitis with predominant cerebellar involvement: report of eight cases with MR and CT imaging features. Eur Radiol 2015;25:719–25 doi:10.1007/s00330-014-3473-6 pmid:25361825

   CrossRefPubMed
10. 10.↵
    2. Basumatary LJ,
    3. Raja D,
    4. Bhuyan D, et al

    . Clinical and radiological spectrum of Japanese encephalitis. J Neurol Sci 2013;325:15–21 doi:10.1016/j.jns.2012.11.007 pmid:23260319

    CrossRefPubMed
11. 11.↵
    2. Misra UK,
    3. Kalita J

    . Overview: Japanese encephalitis. Prog Neurobiol 2010;91:108–20 doi:10.1016/j.pneurobio.2010.01.008 pmid:20132860

    CrossRefPubMed
12. 12.↵
    2. Rebai I,
    3. Ben Rhouma H,
    4. Kraoua I, et al

    . Postencephalitic parkinsonism and selective involvement of substantia nigra in childhood. Brain Dev 2015;37:153–57 doi:10.1016/j.braindev.2014.03.009 pmid:24745788

    CrossRefPubMed
13. 13.↵
    2. Bosanko CM,
    3. Gilroy J,
    4. Wang AM, et al

    . West Nile virus encephalitis involving the substantia nigra: neuroimaging and pathologic findings with literature review. Arch Neurol 2003;60:1448–52 doi:10.1001/archneur.60.10.1448 pmid:14568817

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Einsiedel L,
    3. Kat E,
    4. Ravindran J, et al

    . MR findings in Murray Valley encephalitis. AJNR Am J Neuroradiol 2003;24:1379–82 pmid:12917132

    Abstract/FREE Full Text
15. 15.↵
    2. Çelik T,
    3. Çelik Ü,
    4. Tolunay O, et al

    . Epstein-Barr virus encephalitis with substantia nigra involvement. J Pediatr Neurosci 2015;10:401–03 doi:10.4103/1817-1745.174436 pmid:26962357

    CrossRefPubMed
16. 16.↵
    2. Ogata A,
    3. Tashiro K,
    4. Pradhan S

    . Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology 2000;55:602 pmid:10953209

    FREE Full Text
17. 17.↵
    2. Renard T,
    3. Daumas-Duport B,
    4. Auffray-Calvier E, et al

    . Cytomegalovirus encephalitis: undescribed diffusion-weighted imaging characteristics—original aspects of cases extracted from a retrospective study, and from literature review. J Neuroradiol 2016;43:371–77 doi:10.1016/j.neurad.2016.03.004 pmid:27137084

    CrossRefPubMed
18. 18.↵
    2. Sener RN

    . Herpes simplex encephalitis: diffusion MR imaging findings. Comput Med Imaging Graph 2001;25:391–97 doi:10.1016/S0895-6111(01)00005-2 pmid:11390193

    CrossRefPubMed
19. 19.↵
    2. Bulakbasi N,
    3. Kocaoglu M,
    4. Tayfun C, et al

    . Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 2006;27:1983–86 pmid:17032879

    Abstract/FREE Full Text
20. 20.↵
    2. Lian Z,
    3. Huang B,
    4. He S, et al

    . Diffusion-weighted imaging in the diagnosis of enterovirus 71 encephalitis. Acta Radiol 2012;53:208–13 pmid:22184685

    CrossRefPubMed
21. 21.↵
    2. Barata Tavares J,
    3. Geraldo AF,
    4. Neto L, et al

    . Diffusion-weighted MR imaging characterization of progressive multifocal leucoencefalopathy (PML) lesions [in Portuguese]. Acta Med Port 2012;25(Suppl 1):34–37 pmid:23177580

    PubMed
22. 22.↵
    2. Pal S,
    3. Sen K,
    4. Biswas NM, et al

    . Clinico-radiological profile and outcome of dengue patients with central nervous system manifestations: a case series in an Eastern India tertiary care hospital. J Neurosci Rural Pract 2016;7:114–24 doi:10.4103/0976-3147.165410 pmid:26933357

    CrossRefPubMed
23. 23.↵
    2. Mehta A,
    3. Mahale RR,
    4. Javali M, et al

    . Diffusion restriction in pons resembling “reverse moustache” in dengue encephalitis. Neurol India 2014;62:683–84 doi:10.4103/0028-3886.149408 pmid:25591689

    CrossRefPubMed
24. 24.↵
    2. Mathew S,
    3. Pandian JD

    . Stroke in patients with dengue. J Stroke Cerebrovasc Dis 2010;19:253–56 doi:10.1016/j.jstrokecerebrovasdis.2009.05.003 pmid:20434057

    CrossRefPubMed
25. 25.↵
    2. Kumar R,
    3. Prakash O,
    4. Sharma BS

    . Intracranial hemorrhage in dengue fever: management and outcome: a series of 5 cases and review of literature. Surg Neurol 2009;72:429–33; discussion 433 doi:10.1016/j.surneu.2009.01.021 pmid:19328535

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Kumar V,
    3. Kataria R,
    4. Mehta VS

    . Dengue hemorrhagic fever: a rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian J Ophthalmol 2011;59:311–12 doi:10.4103/0301-4738.82002 pmid:21666319

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Kumar R,
    3. Prakash O,
    4. Sharma BS

    . Dengue hemorrhagic fever: a rare presentation as atypical acute subdural hematoma. Pediatr Neurosurg 2008;44:490–92 doi:10.1159/000180305 pmid:19066441

    CrossRefPubMedWeb of Science
28. 28.↵
    2. de Souza LJ,
    3. Martins AL,
    4. Paravidini PC, et al

    . Hemorrhagic encephalopathy in dengue shock syndrome: a case report. Braz J Infect Dis 2005;9:257–61 pmid:16224633

    PubMed
29. 29.↵
    2. Sohoni CA

    . Bilateral symmetrical parieto occipital involvement in dengue infection. Ann Indian Acad Neurol 2015;18:358–59 doi:10.4103/0972-2327.160096 pmid:26425023

    CrossRefPubMed
30. 30.↵
    Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. Epidemiology, Burden of Disease and Transmission. https://www.ncbi.nlm.nih.gov/books/NBK143159/. Accessed November 14, 2017.
31. 31.↵
    2. Puccioni-Sohler M,
    3. Rosadas C

    . Advances and new insights in the neuropathogenesis of dengue infection. Arq Neuropsiquiatr 2015;73:698–703 doi:10.1590/0004-282X20150074 pmid:26222363

    CrossRefPubMed
32. 32.↵
    2. Bhoopat L,
    3. Bhamarapravati N,
    4. Attasiri C, et al

    . Immunohistochemical characterization of a new monoclonal antibody reactive with dengue virus-infected cells in frozen tissue using immunoperoxidase technique. Asian Pac J Allergy Immunol 1996;14:107–13 pmid:9177824

    PubMedWeb of Science